Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20230926 (AU)

234
Gene and protein biomarkers
966
Simple mutations
372
Variant groups
134
Protein expressions
147
Amplification deletions
261
Fusions and Rearrangements
5
Splice variants
9
Methylations
20
Germline mutations
35
Common cancers
65
T1
53
T2
112
T3
219
T4
10
R1
139
R2
18
Less common cancers
9
T1
19
T2
27
T3
78
T4
0
R1
13
R2
138
Rare cancers
38
T1
37
T2
79
T3
276
T4
7
R1
98
R2